Legal bases for ‘A.I. New Drug R&D Investment Standards’

Published: 2018-01-31 11:54:52

Updated: 2018-01-31 11:54:52

A revision bill was proposed to respond to the issue of having reverse effects by conflicts against the current regulations when developing new drugs using artificial intelligence(A.I.).

The Minjoo Party Rep. Jae-Sae Oh announced this as representatively proposing the ‘Revision Bill to the Special Act for Pharmaceutical Industry Promotion and Support’ on the 29^th.

Recently, the high-tech indu...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.